by The global Refractive Surgery Devices market size is expected to be worth around US$ 300.8 Mn by 2030, according to a new report by Vision Research Reports.
Refractive Surgery Devices Market (By Application: Myopia, Hyperopia, Astigmatism, Presbyopia, Dry Eyes; By Product: Lasers, Microkeratome, Aberrometers, Others; By End-use: Hospitals, Ambulatory Surgery Centers, Ophthalmology Clinics) – Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030
Get Sample Copy of This Report@ https://www.visionresearchreports.com/report/sample/38310
Report Insight
| Report Coverage | Details |
| Market Size | US$ 300.8 Mn by 2030 |
| Growth Rate | CAGR of 10.7% From 2021 to 2030 |
| Base year | 2020 |
| Historic Data | 2017 to 2020 |
| Forecast Period | 2021 to 2030 |
| Segments Covered | Application, Product, End use |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
| Companies Mentioned | Johnson & Johnson Services, Inc.; Carl Zeiss Meditec AG; Alcon; Bausch & Lomb Incorporated; Quantel Medical; TOPCON CORPORATION; Essilor; NIDEK CO., LTD.; SCHWIND eye-tech-solutions |
Report Highlights
Myopia held the largest share of 30.1% in 2020 and is expected to grow at a moderate rate during the forecast period. The prevalence of myopia is increasing globally at a high rate, with a significant increase in the risks of vision impairment. As per the WHO, countries in which the prevalence of myopia has been estimated and measured as low in the past (e.g. India) will have major increases by 2050. Hyperopia held a significant share in 2020 as it is a frequent refractive disease that affects both children and adults. The frequently used method for medically correcting hyperopia is excimer laser surgery (193 nm).
The astigmatism segment is expected to grow at the fastest rate of 10.4% during the forecast period. The astigmatism segment is anticipated to boom in the market due to the advancements in technology and the increased rate of astigmatism disorder. According to the American Optometric Association, almost everyone has some degree of astigmatism, which can be corrected by most forms of refractive surgery. This is expected to boost the segment growth during the forecast period.
The lasers segment held the largest revenue share of 44.9% in 2020 owing to the increased usage of laser surgeries for vision correction and technological advancements. The segment will expand at the fastest CAGR from 2021 to 2028.LASIK and other laser refractive surgeries, including PRK and LASEK, are in high demand. This is due to decreasing adoption of eyeglasses or contact lenses for vision correction over refractive surgery due to the high success rate. The Refractive Surgery Council (RSC) strongly started 2021 with a nearly 30%increase in laser vision correction procedures yearly.
The microkeratome segment is expected to expand at a healthy CAGR over the forecast period. The fast expansion of the geriatric population and the rise in the frequency of eye diseases are expected to drive the segment. Furthermore, technological modifications to the blade angle approach, blade’s oscillation frequency, and the blade’s material have been attempted to improve flap cutting and decrease uneven astigmatism, which is a significant factor fueling the segment growth.
The hospitals segment held the largest share of nearly 47.0% in 2020. The procurement of ophthalmic refractive surgical devices in these settings due to their longer shelf life is expected to contribute to the segment growth. Increased refractive surgeries, improved healthcare facilities, and favorable reimbursement policies are some of the factors expected to propel the growth of the hospitals segment at a profitable rate over the projected period. Furthermore, the growing number of hospitals in emerging countries and the improvement of existing eye care infrastructure are expanding the market.
Ambulatory surgical centers are anticipated to grow at the fastest rate during the forecast period. The rising popularity of ambulatory surgical centers is due to convenience, closeness, and reduced costs for patients and insurance. Patients may find that ambulatory surgical centers provide more convenience than hospital OPDs, such as the ability to schedule surgery more quickly. This is expected to boost the segment growth.
North America held the largest share of over 30.0%. High incidence of refractive errors, the presence of significant market players, and the availability of effective reimbursement policies are expected to contribute to the regional market growth. According to the WHO statistics, the number of people aged 65 years and above in the country is expected to reach 78 million by 2035, which will have a positive impact on product demand. Moreover, the implementation of advanced technologies for the development of surgical products is expected to augment the market growth in the region.
Key Players
- Johnson & Johnson Services, Inc.
- Carl Zeiss Meditec AG
- Alcon
- Bausch & Lomb Incorporated
- Quantel Medical
- TOPCON CORPORATION
- Essilor
- NIDEK CO., LTD.
- SCHWIND eye-tech-solutions
Market Segmentation
- Application Outlook
- Myopia
- Hyperopia
- Astigmatism
- Presbyopia
- Dry Eyes
- Product Outlook
- Lasers
- Microkeratome
- Aberrometers
- Others
- End-use Outlook
- Hospitals
- Ambulatory Surgery Centers
- Ophthalmology Clinics
- Regional Outlook
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Asia Pacific
- Japan
- China
- India
- Thailand
- South Korea
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Middle East and Africa
- South Africa
- Saudi Arabia
- UAE
- North America
Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/38310
The study objectives of this report are:
- To analyze and study the global market capacity, production, value, consumption, status (2017-2020) and forecast (2021-2030);
- Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- To define, describe and forecast the market by type, application and region.
- To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
- To identify significant trends and factors driving or inhibiting the market growth.
- To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
- To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
- To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Refractive Surgery Devices Market, By Product
7.1. Refractive Surgery Devices Market, by Product, 2021-2030
7.1.1. Lasers
7.1.1.1. Market Revenue and Forecast (2016-2030)
7.1.2. Microkeratome
7.1.2.1. Market Revenue and Forecast (2016-2030)
7.1.3. Aberrometers
7.1.3.1. Market Revenue and Forecast (2016-2030)
7.1.4. Others
7.1.4.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global Refractive Surgery Devices Market, By Application
8.1. Refractive Surgery Devices Market, by Application, 2021-2030
8.1.1. Myopia
8.1.1.1. Market Revenue and Forecast (2016-2030)
8.1.2. Hyperopia
8.1.2.1. Market Revenue and Forecast (2016-2030)
8.1.3. Astigmatism
8.1.3.1. Market Revenue and Forecast (2016-2030)
8.1.4. Presbyopia
8.1.4.1. Market Revenue and Forecast (2016-2030)
8.1.5. Dry Eyes
8.1.5.1. Market Revenue and Forecast (2016-2030)
Chapter 9. Global Refractive Surgery Devices Market, By End User
9.1. Refractive Surgery Devices Market, by End User, 2021-2030
9.1.1. Hospitals
9.1.1.1. Market Revenue and Forecast (2016-2030)
9.1.2. Ambulatory Surgery Centers
9.1.2.1. Market Revenue and Forecast (2016-2030)
9.1.3. Ophthalmology Clinics
9.1.3.1. Market Revenue and Forecast (2016-2030)
Chapter 10. Global Refractive Surgery Devices Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Product (2016-2030)
10.1.2. Market Revenue and Forecast, by Application (2016-2030)
10.1.3. Market Revenue and Forecast, by End User (2016-2030)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Product (2016-2030)
10.1.4.2. Market Revenue and Forecast, by Application (2016-2030)
10.1.4.3. Market Revenue and Forecast, by End User (2016-2030)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Product (2016-2030)
10.1.5.2. Market Revenue and Forecast, by Application (2016-2030)
10.1.5.3. Market Revenue and Forecast, by End User (2016-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Product (2016-2030)
10.2.2. Market Revenue and Forecast, by Application (2016-2030)
10.2.3. Market Revenue and Forecast, by End User (2016-2030)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Product (2016-2030)
10.2.4.2. Market Revenue and Forecast, by Application (2016-2030)
10.2.4.3. Market Revenue and Forecast, by End User (2016-2030)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Product (2016-2030)
10.2.5.2. Market Revenue and Forecast, by Application (2016-2030)
10.2.5.3. Market Revenue and Forecast, by End User (2016-2030)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Product (2016-2030)
10.2.6.2. Market Revenue and Forecast, by Application (2016-2030)
10.2.6.3. Market Revenue and Forecast, by End User (2016-2030)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Product (2016-2030)
10.2.7.2. Market Revenue and Forecast, by Application (2016-2030)
10.2.7.3. Market Revenue and Forecast, by End User (2016-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Product (2016-2030)
10.3.2. Market Revenue and Forecast, by Application (2016-2030)
10.3.3. Market Revenue and Forecast, by End User (2016-2030)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Product (2016-2030)
10.3.4.2. Market Revenue and Forecast, by Application (2016-2030)
10.3.4.3. Market Revenue and Forecast, by End User (2016-2030)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Product (2016-2030)
10.3.5.2. Market Revenue and Forecast, by Application (2016-2030)
10.3.5.3. Market Revenue and Forecast, by End User (2016-2030)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Product (2016-2030)
10.3.6.2. Market Revenue and Forecast, by Application (2016-2030)
10.3.6.3. Market Revenue and Forecast, by End User (2016-2030)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Product (2016-2030)
10.3.7.2. Market Revenue and Forecast, by Application (2016-2030)
10.3.7.3. Market Revenue and Forecast, by End User (2016-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Product (2016-2030)
10.4.2. Market Revenue and Forecast, by Application (2016-2030)
10.4.3. Market Revenue and Forecast, by End User (2016-2030)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Product (2016-2030)
10.4.4.2. Market Revenue and Forecast, by Application (2016-2030)
10.4.4.3. Market Revenue and Forecast, by End User (2016-2030)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Product (2016-2030)
10.4.5.2. Market Revenue and Forecast, by Application (2016-2030)
10.4.5.3. Market Revenue and Forecast, by End User (2016-2030)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Product (2016-2030)
10.4.6.2. Market Revenue and Forecast, by Application (2016-2030)
10.4.6.3. Market Revenue and Forecast, by End User (2016-2030)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Product (2016-2030)
10.4.7.2. Market Revenue and Forecast, by Application (2016-2030)
10.4.7.3. Market Revenue and Forecast, by End User (2016-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Product (2016-2030)
10.5.2. Market Revenue and Forecast, by Application (2016-2030)
10.5.3. Market Revenue and Forecast, by End User (2016-2030)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Product (2016-2030)
10.5.4.2. Market Revenue and Forecast, by Application (2016-2030)
10.5.4.3. Market Revenue and Forecast, by End User (2016-2030)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Product (2016-2030)
10.5.5.2. Market Revenue and Forecast, by Application (2016-2030)
10.5.5.3. Market Revenue and Forecast, by End User (2016-2030)
Chapter 11. Company Profiles
11.1. Johnson & Johnson Services, Inc.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Carl Zeiss Meditec AG
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Alcon
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Bausch & Lomb Incorporated
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Quantel Medical
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. TOPCON CORPORATION
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Essilor
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. NIDEK CO., LTD.
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. SCHWIND eye-tech-solutions
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/38310
About Us: Our team of skilled and experienced analysts specializes in troubleshooting problems faced by our clients. For comprehensive summary of our services and market research requirements for Global industry.
Contact Us:
call: +1 9197 992 333
Vision Research Report
Any Assistance, Email – sales@visionresearchreports.com
